Matt Might is an active advisor to the newly established Undiagnosed Disease Network Coordinating Center at Harvard University. He is passionate about patient-driven precision medicine, accelerating drug development in rare diseases, and bending the cost curve in medical research with computation and social media. He recently co-authored a white paper for the President’s precision medicine initiative.
Save the date!
Please join on May 15-16, 2025